# A Study of Evacetrapib in Healthy Female Participants

> **NCT01746732** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 23 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Ortho-Cyclen
- **DRUG:** Evacetrapib

## Key facts

- **NCT ID:** NCT01746732
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01746732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01746732, "A Study of Evacetrapib in Healthy Female Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01746732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*